NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Multiple Sclerosis: FutureMS-2 - an Observational Cohort and Scottish Precision Medicine Study
Multiple Sclerosis: FutureMS-2 - an Observational Cohort and Scottish Precision Medicine Study

NCT06001138

Enrolling By InvitationN/A

Sponsor: University of Edinburgh

Conditions: Multiple Sclerosis

Countries: United Kingdom

FutureMS is a project created in direct response to frequent questions people with MS ask their doctors. Every person newly diagnosed wants to know how MS will affect them over their life and what can be done to stop the disease progressing and improve their quality of life. FutureMS aims to help answer those questions. The original FutureMS study provided a snapshot of the impact of MS within a year of diagnosis. However, MS is a long-term condition and so the investigators now want to better understand the impact of MS, on the same individuals, after approximately 5 and 10 years of living with MS. This is the purpose of FutureMS-2.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Previous participants in FutureMS cohort
* Capacity to provide informed consent

Exclusion Criteria:

* Not a participant of FutureMS inception cohort
* Contraindication to MR brain imaging
Locations (5)
  • Aberdeen, United Kingdom
  • Dundee, United Kingdom
  • Edinburgh, United Kingdom
  • Glasgow, United Kingdom
  • Inverness, United Kingdom